AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD
Clinical trial NCT05683379 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05683379
- Sponsor
- REGENXBIO Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-20
- Primary completion
- 2026-06-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.